Our CDI researchers and clinicians attack diabetes and related diseases in a comprehensive way with top programs focused on insulin-producing islets, type 1 diabetes (T1D), type 2 diabetes (T2D), metabolism, obesity, nutrition, and the complications and burdens of diabetes.
CDI basic science research is the foundation of groundbreaking discoveries that pave the way for new treatments, prevention strategies, and potential cures for diabetes. By exploring the fundamental biological processes behind diabetes, our scientists can identify key mechanisms that contribute to the disease's development and progression. These insights are crucial for developing innovative therapies that target the root causes, rather than just the symptoms, of diabetes. Without the critical work of basic science, advancements in patient care, precision medicine, and long-term solutions to prevent or cure diabetes would not be possible.
Islet Program
The basic islet biology research programs at the University of Michigan continues to uncover important new aspects of islet biology, championed by world leaders in the study of islet organelle function in diabetes.
CDI supports the U-M basic islet biology program, embracing new translational research efforts geared to impact human health. As islet dysfunction is central to the pathophysiology of all forms of diabetes, the islet biology research community at Michigan continues to generate new understanding as we push towards future therapies to better meet the needs of those with diabetes.